Subscribe
24 Oct 2024 11:22 AM
In conversation with Bhavna Kewalramani, Sanofi India and Atul Suri, Alembic Pharmaceuticals.
28 Aug 2025 12:21 PM
28 Aug 2025 10:57 AM
28 Aug 2025 10:39 AM
28 Aug 2025 9:04 AM
20 Aug 2025 10:28 AM
19 Aug 2025 10:19 AM
18 Aug 2025 9:23 AM
15 Aug 2025 9:00 AM